We are live on ! Find out more
VERV

Verve Therapeutics
VERV

Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

6 hedge funds and large institutions have $1.24M invested in Verve Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

81.59% less ownership

Funds ownership: 81.84% → 0.26% (-82%)

97% less funds holding

Funds holding: 175 → 6 (-169)

100% less capital invested

Capital invested by funds: $819M → $1.24M (-$818M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 169

Holders
6
Holders Change
-169
Holders Change %
-96.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
169
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$955K
2
IA
IFP Advisors
Florida
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
-$137M
2
BlackRock
BlackRock
New York
-$82.6M
3
PCM
Pentwater Capital Management
Florida
-$75.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$47.1M
5
CC
Casdin Capital
New York
-$46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
76
Arrowstreet Capital
Massachusetts
– -$556K -49,536 Closed
Franklin Resources
77
Franklin Resources
California
– -$537K -47,783 Closed
Wells Fargo
78
Wells Fargo
California
– -$534K -47,566 Closed
Group One Trading
79
Group One Trading
Illinois
– -$507K -45,160 Closed
HCA
80
Harbor Capital Advisors
Illinois
– -$501K -44,601 Closed
ProShare Advisors
81
ProShare Advisors
Maryland
– -$492K -43,787 Closed
TSS
82
Two Sigma Securities
New York
– -$487K -43,402 Closed
IIM
83
INTECH Investment Management
Florida
– -$472K -41,999 Closed
MIM
84
MetLife Investment Management
New Jersey
– -$449K -39,992 Closed
A
85
AlphaQuest
New York
– -$443K -39,455 Closed
GCP
86
GSA Capital Partners
United Kingdom
– -$437K -38,912 Closed
T. Rowe Price Associates
87
T. Rowe Price Associates
Maryland
– -$401K -35,697 Closed
SEI Investments
88
SEI Investments
Pennsylvania
– -$379K -33,785 Closed
Commonwealth Equity Services
89
Commonwealth Equity Services
Massachusetts
– -$370K -32,954 Closed
MFG
90
Merit Financial Group
Georgia
– -$366K -32,612 Closed
AG
91
Algert Global
California
– -$361K -32,185 Closed
TAL
92
TIG Advisors LLC
New York
– -$360K -32,095 Closed
PCM
93
Prelude Capital Management
New York
– -$345K -30,718 Closed
HM
94
Harvest Management
New York
– -$337K -30,000 Closed
HSBC Holdings
95
HSBC Holdings
United Kingdom
– -$307K -27,149 Closed
CIM
96
CIM Investment Management
Pennsylvania
– -$296K -26,378 Closed
WHG
97
Westwood Holdings Group
Texas
– -$293K -26,097 Closed
YIH
98
Y-Intercept (HK)
Hong Kong
– -$289K -25,736 Closed
Manulife (Manufacturers Life Insurance)
99
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$280K -24,926 Closed
Cerity Partners
100
Cerity Partners
New York
– -$262K -23,291 Closed
2 3
4
5 6

VERV Hedge Fund Activity: Q3 2025 in Review

6 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q3 2025, worth a combined $1.24M — down 100% from $819M a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of VERV and 0 opened new positions — a net loss of 169 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $955K. The largest seller was Alphabet Inc, exiting entirely with an estimated $137M sold.

  • 6 institutional investors held Verve Therapeutics (VERV) as of Q3 2025, down from 175 in Q2 2025.
  • Funds reported $1.24M of Verve Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Verve Therapeutics positions in Q3 2025 and 169 closed out, a net change of -169 holders.
  • The largest Verve Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $955K added.
  • The largest Verve Therapeutics seller in Q3 2025 was Alphabet Inc, an estimated $137M sold.

Based on aggregated 13F filings for Q3 2025.